CDSCO License for Cortical electrode.
Medical Device Information
Intended Use
A cortical electrode is an electrode which is temporarily placed on the surface of the brain for stimulating the brain or recording the brain's electrical activity

Comprehensive Guide to CDSCO Licensing for Cortical Electrodes (Class D Neurological Device)
As specialists with over 25 years of experience in medical device regulatory affairs, we have successfully guided more than 500 companies through the complex CDSCO licensing process. If you are manufacturing or importing a Cortical Electrode, a Class D neurological device used to stimulate or record brain electrical activity, understanding the regulatory landscape is crucial to ensure compliance and timely market access in India.
CDSCO Regulatory Framework for Cortical Electrodes
The Central Drugs Standard Control Organization (CDSCO) governs the approval and regulation of medical devices in India under the Medical Device Rules 2017. Cortical electrodes fall under the Class D category — the highest risk class due to their direct interaction with the central nervous system.
The regulatory framework mandates stringent controls, including mandatory testing, documentation, and audits by CDSCO authorities, reflecting the critical safety concerns associated with neurological devices.
Risk Classification and License Requirements for Cortical Electrodes
According to the Medical Device Classification, Cortical Electrodes are Class D devices because they are invasive and used for critical neurological applications. This classification requires manufacturers and importers to obtain an MD9 Manufacturing License and MD15 Import License respectively, both issued by the CDSCO Central Licensing Authority.
License Type | Applicable For | Authority | Timeline | Fees (INR) |
---|---|---|---|---|
MD9 Manufacturing | Class C & D Manufacturers | CDSCO Central Office | 4-5 months | ₹50,000 + ₹1,000 per product |
MD15 Import | Importers of Class D | CDSCO Central Office | 5-6 months | ₹2,25,000 + ₹1,50,000 per product (USD converted approx) |
Manufacturing License Process for Cortical Electrodes (MD9)
The MD9 license is essential for manufacturing Class D cortical electrodes in India. Here's a stepwise overview:
Test License (MD13): The process begins with obtaining a Test License under Form MD13, valid for 1.5 to 2 months. This allows you to produce the product for testing purposes.
Product Testing: You must get your cortical electrode tested at CDSCO-approved laboratories. Testing labs specializing in neurological device parameters can be found in the Testing Laboratories Directory.
Documentation Preparation: Compile comprehensive documentation including Device Master File, Plant Master File, Risk Management File, Essential Principles Checklist, and QMS documents.
License Application Submission (Form MD7): Submit your MD9 application via the CDSCO MD Online Portal with all supporting documents.
Audit & Inspection: CDSCO inspectors will conduct a detailed audit of your manufacturing facility and quality systems.
Query Resolution: Respond promptly to any queries raised by the department or inspectors.
License Grant: Upon successful compliance, the manufacturing license is issued on Form MD9.
For more detailed steps, refer to our MD9 License Guide.
Manufacturing License Documents Required for Cortical Electrodes
- Company Constitution and Incorporation Certificates
- Proof of Ownership/Rent Agreement of Manufacturing Premises
- Detailed Device Master File (including design, materials, biocompatibility)
- Plant Master File detailing manufacturing processes and infrastructure (Plant Master File Guide)
- Essential Principles Checklist confirming compliance with safety and performance requirements
- Risk Management File demonstrating hazard analysis and mitigation strategies (Risk Management Reference)
- Test Reports from CDSCO-approved labs
- Labels and Instructions for Use (IFU) compliant with CDSCO requirements
- Quality Management System (QMS) documentation including ISO 13485:2016 certification
- Fire and Pollution NOCs
- Details of Technical Staff
Import License Process for Cortical Electrodes (MD15)
If you intend to import Class D cortical electrodes, the MD15 license is mandatory. The process is as follows:
Document Compilation: Prepare documents such as the manufacturing license from the country of origin, Free Sale Certificate, ISO 13485:2016, CE certificate (if applicable), Device and Plant Master Files, and wholesale license.
Application Submission: Submit your application on the CDSCO MD Online Portal using Form MD14.
Review and Queries: CDSCO reviews the application and may raise queries for additional information.
License Issuance: Upon satisfactory compliance, the MD15 Import License is granted.
More insights are available in our Import License Guide.
Import License Documents Required
- Valid Manufacturing License from Country of Origin
- Free Sale Certificate
- ISO 13485:2016 Certificate
- CE Certificate (if applicable)
- Device Master File
- Plant Master File
- Wholesale License for distribution in India
- Company Constitution and Incorporation Documents
Timeline and Processing Duration
Process Step | Approximate Duration |
---|---|
Test License (MD13) | 1.5 to 2 months |
Product Testing | 3 to 4 weeks |
MD9 Manufacturing License | 4 to 5 months (including above steps) |
MD15 Import License | 5 to 6 months |
This timeline is based on typical regulatory processing but can vary depending on the completeness of documentation and response time to queries.
Government Fees and Costs
- MD9 Manufacturing License: ₹50,000 per application + ₹1,000 per product
- MD15 Import License: Approx USD 3,000 per site + USD 1,500 per product (equivalent INR values apply)
- Testing Fees: Variable depending on laboratory and scope
Budgeting for these fees upfront helps avoid delays.
Common Challenges and Solutions
Challenge: Delays due to incomplete or inconsistent documentation.
Solution: Engage experienced regulatory consultants to perform a thorough gap analysis of your Device Master File and quality system before submission.
Challenge: Difficulty in coordinating testing with CDSCO-approved labs.
Solution: Plan testing schedules early and maintain clear communication with labs listed in the CDSCO Testing Laboratories.
Challenge: Queries from CDSCO inspectors requiring technical clarifications.
Solution: Prepare detailed responses with supporting evidence and ensure your technical staff is well-versed with regulatory requirements.
Expert Consultation and Support
Our team has supported over 500 companies in obtaining CDSCO licenses for neurology-related Class D devices such as cortical electrodes. We offer end-to-end services:
- Gap assessments of your QMS and documentation
- Device and Plant Master File preparation
- Coordination with testing labs and notified bodies
- Application preparation and submission via the CDSCO MD Online Portal
- Audit and inspection readiness
- Timely query resolution
Getting Started with Your CDSCO License Application
Assess Your Device Classification: Confirm your cortical electrode’s classification and licensing requirements using trusted resources.
Prepare Documentation: Begin compiling your Device Master File and Plant Master File, focusing on the neurological application specifics.
Apply for Test License (MD13): Initiate the process by applying for the test license to enable product testing.
Schedule Testing: Coordinate with CDSCO-approved labs early to avoid bottlenecks.
Engage Experts: Consider professional regulatory consultancy to navigate complexities and reduce approval timelines.
Submit Manufacturing License Application (MD9): Once testing is complete, submit your application with comprehensive documentation.
Prepare for Audit: Ensure your manufacturing site and QMS are audit-ready to meet CDSCO standards.
By following these precise steps and leveraging our deep expertise, you can successfully obtain your CDSCO licenses and bring your cortical electrode to the Indian market with confidence.
For personalized assistance or detailed queries, reach out to our regulatory consultants who specialize in high-risk neurological medical devices.